Celldex Therapeutics

Ovid eyes next chapter with CEO transition—Chutes & Ladders

Ovid's Levin set to become chairman as its next CEO stands ready. FDA’s oncology head takes top CDER post. Metagenomi shuffles CEO in reorg. Plus more.

Darren Incorvaia , Zoey Becker Nov 14, 2025 8:30am

Celldex ends esophageal program despite hitting primary endpoint

Aug 20, 2025 6:42am

reshuffle pipeline target reorganize shift change

Celldex drops phase 1 tumor bispecific to focus on inflammation

Nov 7, 2024 7:25am

target reach ladder climb meet win beat competition

Celldex anti-cKIT antibody reduces hives in another phase 2 test

Jul 30, 2024 5:50am

soccer kick off ball football field play game crowd boots cleats

Celldex laces up next to Big Pharmas with chronic hive drug

Nov 6, 2023 10:17am

After cancer flops, Celldex shows promise in treating hives

Jul 12, 2021 8:05am